The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma

PURPOSE: To determine if the addition of bevacizumab to radiation therapy and temozolomide, followed by bevacizumab, temozolomide and irinotecan for newly diagnosed glioblastoma patients is safe and effective. EXPERIMENTAL DESIGNS: Seventy five patients with newly diagnosed glioblastoma were enrolle...

Full description

Saved in:
Bibliographic Details
Main Authors: Vredenburgh, James J., Desjardins, Annick, Reardon, David A., Peters, Katherine B., Herndon, James E., Marcello, Jennifer, Kirkpatrick, John P., Sampson, John H., Bailey, Leighann, Threatt, Stevie, Friedman, Allan H., Bigner, Darell D., Friedman, Henry S.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117928/
https://ncbi.nlm.nih.gov/pubmed/21531816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0120
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items